PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combining treatments boosts some smokers' ability to quit

2014-06-17
(Press-News.org) DURHAM, N.C. -- Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine.

The findings, published online June 17, 2014, in the American Journal of Psychiatry, also support using an adaptive treatment model to determine which smokers are likely to succeed in quitting with nicotine replacement alone before trying additional therapies.

"The findings offer a potential practical treatment approach that can identify smokers who don't respond to a single conventional treatment, but may benefit enormously from a combination of treatments," said Jed Rose, Ph.D., director of the Duke Center for Smoking Cessation and the study's lead author.

Rose and his colleagues have developed adaptive models for smoking cessation that tailor treatment regimens based on a person's likelihood of successfully quitting. Smokers start using a nicotine patch prior to quitting, and based on their reduction in smoking, researchers then determine who is likely to successfully quit with or without additional treatments.

"Using a safe and inexpensive nicotine patch, we can predict a smoker's success or failure," Rose said. "If a smoker has a low likelihood of succeeding, we can avert failure before it happens using a step-by-step algorithm to switch a smoker to a treatment that's more likely to help."

Current smoking cessation treatments – including nicotine replacement, bupropion (sold under the brand name Zyban) and varenicline (sold as Chantix) – have modest long-term success rates. Research has shown that less than 25 percent of smokers remain abstinent a year after treatment.

"It's clear that we need to improve success rates for smoking cessation, and it is thought that combining treatments could add to the efficacy," Rose said. "Combining two therapies, especially if they act by different mechanisms, may address different aspects of the addiction."

To measure the benefit of combining treatments, the researchers enrolled 349 adults who reported smoking 10 or more cigarettes a day. A six-item questionnaire measured the smokers' level of nicotine dependence. All participants were given nicotine patches prior to quitting.

After a week on the nicotine patch, the 222 participants who did not cut their smoking by 50 percent while on the patch were randomly assigned to take either varenicline and a placebo or a combination of varenicline and bupropion.

The participants took the assigned treatments for 12 weeks, and were followed periodically for six months. The varenicline and bupropion were generally well tolerated, with side effects including headache, dry mouth, irritability, insomnia, vivid dreams and changes in taste.

The researchers observed an overall benefit of adding bupropion to varenicline, with 39.8 percent of participants on the combination treatment abstaining from smoking at weeks 8-11 after the target quit date, versus 25.9 percent taking varenicline alone.

The combined treatment had a much greater effect on male smokers and those highly dependent on nicotine, while no significant difference was seen in female smokers or those with lower levels of nicotine dependence.

Smokers who were both male and highly dependent saw the greatest benefit of the combination of treatments.

"Highly dependent male smokers had a boost in quit rates from 14 percent on varenicline alone to 61 percent with the combination treatment, which is a dramatic increase," Rose said.

"While there may be some drawbacks to prescribing two smoking cessation treatments, such as cost or possible side effects, this study gives us a simple strategy to find those who would benefit the most from combined treatment, and spare others who may not benefit."

The researchers said additional studies are needed to investigate the mechanisms that may account for the differences in treatment responses across genders and other populations of smokers.

INFORMATION: The study was coauthored by Frederique Behm of the Duke Center for Smoking Cessation, and was supported by National Institute on Drug Abuse (1P50 DA027840) and Philip Morris USA. The authors have consulting and patent purchase agreements with Philip Morris International for nicotine inhalation technology and consulting agreements with Targacept and Novartis.


ELSE PRESS RELEASES FROM THIS DATE:

Minimizing belief in free will may lessen support for criminal punishment

2014-06-17
Exposure to information that diminishes free will, including brain-based accounts of behavior, seems to decrease people's support for retributive punishment, according to research published in Psychological Science, a journal of the Association for Psychological Science. People who learned about neuroscientific research, either by reading a magazine article or through undergraduate coursework, proposed less severe punishment for a hypothetical criminal than did their peers. The findings suggest that they did so because they saw the criminal as less blameworthy. "There ...

Survey finds e-cigarette online market on fire

2014-06-17
Researchers at the University of California, San Diego School of Medicine have completed the first comprehensive survey of e-cigarettes for sale online and the results, they believe, underscore the complexity in regulating the rapidly growing market for the electronic nicotine delivery devices. The survey, published in a June 16 special supplement of the journal Tobacco Control, found that 10 new e-cigarette brands entered the Internet marketplace every month, on average, from 2012 to 2014, and that there are currently 466 e-cigarette brands online, offering more than ...

E-cigarettes in Europe used mostly by the young, current smokers, would-be quitters

2014-06-17
Boston, MA – Most Europeans who have tried electronic cigarettes (e-cigarettes) are young, current smokers, or those who recently tried quitting regular cigarettes, according to a new study from Harvard School of Public Health (HSPH). Nearly 30 million Europeans have tried the battery-operated cigarettes, in spite of the fact that not much is known about their potential risks to health or whether they help smokers trying to quit. The study will appear online on June 16, 2014 in Tobacco Control. It is the largest study to date on e-cigarette use in the European Union. "As ...

Study: Commuting times stay constant even as distances change

2014-06-17
How much commuting can you tolerate? A new study by MIT researchers shows that across countries, people assess their commutes by the time it takes them to complete the trip, generally independent of the distance they have to travel — as long as they have a variety of commuting options to chose from. The study, which compares commuting practices in five locations on four continents, also demonstrates the methodological validity of using mobile phone data to create an accurate empirical picture of commuting. "Every country has had its own different way of doing things ...

Great white shark population in good health along California coast, UF study finds

2014-06-17
GAINESVILLE, Fla. --- The Great White Shark is not endangered in the Eastern North Pacific, and, in fact, is doing well enough that its numbers likely are growing, according to an international research team led by a University of Florida researcher. George Burgess, director of the Florida Program for Shark Research, said the wide-ranging study is good news for shark conservation. The study, to be published June 16 in the journal PLOS ONE, indicates measures in place to protect the ocean's apex predator are working. Scientists reanalyzed 3-year-old research that indicated ...

Despite recent problems, support for the Massachusetts health insurance law remains high

2014-06-17
Boston, MA — A new poll by The Boston Globe and Harvard School of Public Health (HSPH) finds, eight years into the state's universal health insurance legislation enacted in 2006, 63% of Massachusetts residents support the law and 18% oppose it, while 7% are not sure, and 12% have not heard or read about the law. The percentage of residents supporting the law remains unchanged since a 2011 Boston Globe/HSPH poll. Support for the law varies by party affiliation, with 77% of Democrats, 60% of Independents, and 49% of Republicans saying they support the legislation. The poll ...

Lower isn't necessarily better for people with high blood pressure

2014-06-16
WINSTON-SALEM, N.C. – June 16, 2014 – For decades, common medical wisdom has been "the lower the better" in treating the approximately one in three people in this country who have high blood pressure. But does that approach result in reduced risk for dangerous heart events? In a study published in the June 16 online edition of JAMA Internal Medicine, researchers at Wake Forest Baptist Medical Center found that lowering systolic blood pressure below 120 does not appear to provide additional benefit for patients. Systolic pressure is the top number in a standard blood pressure ...

Beta-blockers before coronary artery bypass grafting surgery not associated with better outcomes

2014-06-16
Bottom Line: Use of beta (β)-blockers in patients who have not had a recent heart attack but were undergoing nonemergency coronary artery bypass grafting (CABG) surgery was not associated with better outcomes. Author: William Brinkman, M.D., of the Cardiopulmonary Research Science and Technology Institute, Dallas, and colleagues. Background: The use of preoperative β-blockers has been associated with a reduction in perioperative mortality for patients undergoing CABG surgery in previous observational studies. Preoperative β-blocker therapy is a national ...

Intervention increased adherence to fecal occult blood testing for colorectal cancer screening

2014-06-16
Bottom Line: A multipart intervention increased adherence rates of annual fecal occult blood testing (FOBT) for colorectal cancer (CRC) screening in vulnerable populations. Author: David W. Baker, M.D., M.P.H., of the Feinberg School of Medicine at Northwestern University, Chicago, and colleagues. Background: The vast majority of CRC screening in the U.S. is by colonoscopy, although studies suggest that FOBT can achieve similar reductions in CRC mortality. Colorectal cancer screening rates are lower among Latinos and people living in poverty. Expanded use of FOBT ...

No adverse cognitive effects in kids breastfed by moms using antiepileptic drugs

2014-06-16
Bottom Line: Breastfeeding by mothers treated with antiepileptic drug (AED) therapy was not associated with adverse effects on cognitive function in children at 6 years. Author: Kimford J. Meador, M.D., of Stanford University, California, and colleagues for the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study Group. Background: Some concern has been raised that breastfeeding by mothers being treated with AED therapy may be harmful to the child because some AEDs can cause neuronal apoptosis (cell death) in immature animal brains. How the Study Was ...

LAST 30 PRESS RELEASES:

New evidence of long-distance travelers in Seddin during the Bronze Age

Newly dated 85-million-year-old dino eggs could improve understanding of Cretaceous climate

From noise to power: A symmetric ratchet motor discovery

Family-based intervention programs are insufficient to prevent childhood obesity, major study finds

Emotions expressed in real-time barrage comments relate to purchasing intentions and imitative behavior

Your genes could prune your gut bugs and protect you from disease

EMBARGOED MEDIA RELEASE: Breathlessness increases long-term mortality risk, Malawi study finds

Permeable inspection of pharmaceuticals goes in-line

Warming rivers in Alaska threaten Chinook salmon populations and Indigenous food security

New multi-disciplinary approach sheds light on the role of mitochondrial DNA mutations in cancer

Worms reveal just how cramped cells really are

Alzheimer’s disease digital resources lacking for Latinos, Hispanics in Los Angeles years after COVID-19, study finds

Chronic disease deaths decline globally, but progress is slowing

The Lancet: Chronic disease deaths decline globally, but progress is slowing

The Lancet: Parent-focused programs insufficient to prevent obesity in toddlers, finds meta-analysis; authors call for a re-think of childhood obesity prevention approaches

Study sheds light on hurdles faced in transforming NHS healthcare with AI

Astrocytic “brake” that blocks spinal cord repair identified

As farm jobs decline, food industry work holds steady

Kennesaw State researcher aiming to move AI beyond the cloud

Revolutionizing impedance flow cytometry with adjustable microchannel height

Treating opioid addiction in jails improves treatment engagement, reduces overdose deaths and reincarceration

Can’t sleep? Insomnia associated with accelerated brain aging

Study links teacher turnover to higher rates of student suspensions, disciplinary referrals

How harmful bacteria hijack crops

Crowded conditions muddle frogs’ mating choices

A new way to guide light, undeterred

Researchers uncover how COVID-19 may linger in cancer patients and affect treatment outcomes

Tiny metal figurines from Sardinia's Nuragic civilization in around 1,000 BC reveal extensive ancient Mediterranean metal trading networks

Natural microfibers may degrade differently to synthetic materials under simulated sunlight exposure in freshwater and seawater conditions, with implications for how such pollutants affect aquatic lif

Indian new mums report better postpartum wellbeing when their own mum acts as their primary support - while women whose mother-in-law is the primary caregiver instead report significantly lower overal

[Press-News.org] Combining treatments boosts some smokers' ability to quit